Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

271 ARTÍCULOS , VIENDO DEL 151 AL 165

Contributions of the ADNI Biostatistics Core

Beckett LA, Saito N, Donohue MC, Harvey DJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Oct;20(10):7331-7339. doi: 10.1002/alz.14159. Epub 2024 Aug 14.

MicroRNA-455-3P as a peripheral biomarker and therapeutic target for mild cognitive impairment and Alzheimer's disease

Islam MA, Sultana OF, Bandari M, Kshirsagar S, Manna PR, Reddy PH.

Ageing Res Rev. 2024 Sep;100:102459. doi: 10.1016/j.arr.2024.102459. Epub 2024 Aug 15.

Towards discovery and implementation of neurophysiologic biomarkers of Alzheimer's disease using entropy methods

Simmatis LER, Russo EE, Altug Y, Murugathas V, Janevski J, Oh D, Chiu Q, Harmsen IE, Samuel N.

Neuroscience. 2024 Oct 18;558:105-113. doi: 10.1016/j.neuroscience.2024.08.017. Epub 2024 Aug 18.

CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease

Lizama BN, Williams C, North HA, Pandey K, Duong D, Di Caro V, Mecca AP, Blennow K, Zetterberg H, Levey AI, Grundman M, van Dyck CH, Caggiano AO, Seyfried NT, Hamby ME.

Alzheimers Dement. 2024 Oct;20(10):6860-6880. doi: 10.1002/alz.14152. Epub 2024 Aug 21.

The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test

Villain N, Paretsky MS.

Neurology. 2024 Sep 10;103(5):e209836. doi: 10.1212/WNL.0000000000209836. Epub 2024 Aug 21.

Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic

Bader I, Groot C, Tan HS, Milongo JA, Haan JD, Verberk IMW, Yong K, Orellina J, Campbell S, Wilson D, van Harten AC, Kok PHB, van der Flier WM, Pijnenburg YAL, Barkhof F, van de Giessen E, Teunissen CE, Bouwman FH, Ossenkoppele R.

Alzheimers Res Ther. 2024 Aug 21;16(1):190. doi: 10.1186/s13195-024-01545-1.

Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's disease

Desai U, Gomes DA, Chandler J, Ye W, Daly M, Kirson N, Dennehy EB.

Curr Med Res Opin. 2024 Oct;40(10):1719-1725. doi: 10.1080/03007995.2024.2394602. Epub 2024 Sep 1.

Building expert consensus regarding sharing of individual research results in Alzheimer's disease research: a Delphi study protocol

Sankary LR, Rico V, Zelinsky M, Webster HS, Lerner AJ, Martinez K, Ford PJ, Tousi B, Leverenz J.

BMJ Open. 2024 Aug 24;14(8):e089242. doi: 10.1136/bmjopen-2024-089242.

Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA

Quaresima V, Pilotto A, Trasciatti C, Tolassi C, Parigi M, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Benussi A, Ashton NJ, Blennow K, Zetterberg H, Giliani S, Brugnoni D, Padovani A.

Neurobiol Aging. 2024 Nov;143:30-40. doi: 10.1016/j.neurobiolaging.2024.08.007. Epub 2024 Aug 22.

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu E, Zhang Y, Wang JZ.

Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x.

Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: an update of the literature

Milos T, Vuic B, Balic N, Farkas V, Nedic Erjavec G, Svob Strac D, Nikolac Perkovic M, Pivac N.

Expert Rev Neurother. 2024 Nov;24(11):1063-1079. doi: 10.1080/14737175.2024.2400683. Epub 2024 Sep 4.

CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis

Zou Y, Wang Y, Ma X, Mu D, Zhong J, Ma C, Mao C, Yu S, Gao J, Qiu L.

Ageing Res Rev. 2024 Nov;101:102485. doi: 10.1016/j.arr.2024.102485. Epub 2024 Sep 4.

Deciphering the role of miRNAs in Alzheimer's disease: Predictive targeting and pathway modulation - A systematic review

Sharma M, Pal P, Gupta SK.

Ageing Res Rev. 2024 Nov;101:102483. doi: 10.1016/j.arr.2024.102483. Epub 2024 Sep 3.

Breaking Barriers in Alzheimer's Disease: the Role of Advanced Drug Delivery Systems

Shekho D, Mishra R, Kamal R, Bhatia R, Awasthi A.

AAPS PharmSciTech. 2024 Sep 5;25(7):207. doi: 10.1208/s12249-024-02923-6.

Pathways to personalized medicine-Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease

Arnold SE, Hyman BT, Betensky RA, Dodge HH.

Alzheimers Dement. 2024 Oct;20(10):7384-7394. doi: 10.1002/alz.14063. Epub 2024 Sep 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias